Peak Bio is a clinical-stage biopharmaceutical company focused on commercializing innovative therapeutics that aim to improve and address significant unmet medical need for patients with inflammatory, rare and specialty diseases and cancer. We will continue to explore and partner with researchers, clinicians, patient advocacy groups, academic institutions, governmental agencies, and our investors to continue to expand treatment options and partnerships to meet those expectations.
Company profile
Ticker
PKBO, PKBOW
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Ignyte Acquisition Corp.
SEC CIK
Corporate docs
IRS number
852448157
PKBO stock data
Latest filings (excl ownership)
NT 10-K
Notice of late annual filing
1 Apr 24
425
Business combination disclosure
5 Mar 24
425
Business combination disclosure
5 Mar 24
8-K
Akari Therapeutics and Peak Bio Announce Definitive Agreement to
5 Mar 24
8-K
Unregistered Sales of Equity Securities
21 Feb 24
8-K
Unregistered Sales of Equity Securities
6 Feb 24
8-K
Entry into a Material Definitive Agreement
29 Jan 24
8-K
Unregistered Sales of Equity Securities
3 Jan 24
8-K
Entry into a Material Definitive Agreement
22 Dec 23
NT 10-Q
Notice of late quarterly filing
16 Nov 23
Financial summary
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 274.37 k | 274.37 k | 274.37 k | 274.37 k | 274.37 k | 274.37 k |
Cash burn (monthly) | 116.60 k | 9.18 k | 1.98 mm | 2.26 mm | 411.14 k | 655.21 k |
Cash used (since last report) | 1.15 mm | 90.78 k | 19.59 mm | 22.34 mm | 4.06 mm | 6.48 mm |
Cash remaining | -878.37 k | 183.59 k | -19.31 mm | -22.06 mm | -3.79 mm | -6.20 mm |
Runway (months of cash) | -7.5 | 20.0 | -9.7 | -9.8 | -9.2 | -9.5 |
Institutional ownership, Q1 2023
57.8% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 7 |
Opened positions | 4 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 68.56 mm |
Total shares | 13.08 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Huh Hoyoung | 8.73 mm | $48.46 mm |
Sbi Investment Korea | 3.62 mm | $20.10 mm |
Flynn James E | 362.50 k | $0.00 |
Phillip MD Frost Et Al | 315.00 k | $0.00 |
Context Capital Management | 25.00 k | $3.00 k |
Flow Traders U.s. | 17.79 k | $0.00 |
Clear Street | 10.46 k | $0.00 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Mar 24 | 2014 Kif-sbi It Investment Fund | Common Stock | Other | Dispose J | No | No | 0 | 167,600 | 0.00 | 0 |
27 Sep 23 | Stephen J LaMond | Common Stock | Buy | Acquire P | No | No | 0 | 2,600 | 0.00 | 19,850 |
26 Sep 23 | Stephen J LaMond | Common Stock | Buy | Acquire P | No | No | 0 | 3,000 | 0.00 | 17,250 |
21 Sep 23 | Huh Hoyoung | Common Stock | Buy | Acquire P | No | No | 0 | 45,000 | 0.00 | 8,382,742 |
20 Sep 23 | Huh Hoyoung | Common Stock | Buy | Acquire P | No | No | 0 | 30,000 | 0.00 | 8,337,742 |
19 Sep 23 | Huh Hoyoung | Common Stock | Buy | Acquire P | No | No | 0 | 50,000 | 0.00 | 8,307,742 |
18 Sep 23 | Stephen J LaMond | Common Stock | Buy | Acquire P | No | No | 0 | 2,500 | 0.00 | 28,500 |
15 Sep 23 | Stephen J LaMond | Common Stock | Buy | Acquire P | No | No | 0 | 26,000 | 0.00 | 26,000 |